Bruker displays mass spec platforms, proteomics advancements

Bruker Daltonics is displaying its mass spectrometry platforms and advances in applied proteomics solutions at the Human Proteome Organisation's (HUPO) annual world congress this week in Sydney.

The autoflex speed is a MALDI-TOF (/TOF) system is designed for enhanced workflows in proteomics research and tissue biomarker and drug imaging. High performance molecular imaging of small molecules including drugs, metabolites and lipids in tissue are available on the MALDI-solariX FTMS platform, said the Billerica, Mass.-based company.

ProteinScape 2.1 proteomics bioinformatics platform is a solution for qualitative and quantitative LC-MS/MS protein analysis and addresses scientists' needs in biomarker profiling, quantification and validation, according to the comapany. The ProteinScape processing pipeline adopts the "HUPO Brain Proteomics Project processing guidelines" and will facilitate the direct submission process of project data adhering to HUPO Proteomics Standards Initiative publishing guidelines, added Bruker.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.